» Articles » PMID: 35741077

Circular RNA As a Novel Biomarker and Therapeutic Target for HCC

Overview
Journal Cells
Publisher MDPI
Date 2022 Jun 24
PMID 35741077
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNA (circRNA) is a kind of endogenous non-coding RNA (ncRNA), which is produced by the reverse splicing of precursor mRNA (pre mRNA). It is widely expressed in a variety of biological cells. Due to the special formation mode, circRNA does not have a 5' terminal cap and 3' poly (A) tail structure. Compared with linear RNA, circRNA is more stable to exonuclease and ribonuclease. In addition, circRNA is structurally conserved, has a stable sequence and is tissue-specific. With the development of high-throughput sequencing and bioinformatics technology, more and more circRNAs have been found. CircRNA plays an important pathophysiological role in the occurrence and development of alcoholic liver injury (ALI), hepatic fibrosis (HF), hepatocellular carcinoma (HCC), and other liver diseases. Our group has been committed to the research of liver disease diagnosis and treatment targets. We review the function and mechanism of circRNA in ALI, HF and HCC, expecting to provide new ideas for the diagnosis, treatment, and prognosis of liver diseases.

Citing Articles

Circular RNA Vav3 mediated ALV-J inhibition of autophagy by modulating the gga-miR-375/CIP2A axis and activating AKT.

Chen L, Xu H, Liu R, Yao Z, Xie Q, Zhang X Poult Sci. 2025; 104(4):104923.

PMID: 39987600 PMC: 11904538. DOI: 10.1016/j.psj.2025.104923.


CircRNA circACTN4 Promotes the Progression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the miR-424-5p/NCAPG/Wnt Axis.

Shan J, Pu J, Chen X, Zhang Y, Li J, Qin L Clin Exp Med. 2025; 25(1):47.

PMID: 39891781 PMC: 11787268. DOI: 10.1007/s10238-025-01573-7.


Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.

Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q Immunotargets Ther. 2024; 13:643-659.

PMID: 39624827 PMC: 11611519. DOI: 10.2147/ITT.S463556.


Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments.

Chi X, Chen Z, Yu J, Xie X, Lin Z, Chen Y J Clin Transl Hepatol. 2024; 12(11):897-906.

PMID: 39544243 PMC: 11557365. DOI: 10.14218/JCTH.2024.00270.


N-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis.

Xu D, Liu Y, Liu Q, Li G, Zhang L, Yu C J Transl Med. 2024; 22(1):1026.

PMID: 39543614 PMC: 11566831. DOI: 10.1186/s12967-024-05745-z.


References
1.
Chen X, Li W, Chen Y, Li X, Li H, Huang H . Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis. Cell Death Dis. 2018; 9(10):1021. PMC: 6170444. DOI: 10.1038/s41419-018-1032-9. View

2.
Guo X, Chen J, Sun F, Wang Y, Pan Q, Fan J . circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. Oxid Med Cell Longev. 2017; 2017:3960197. PMC: 5605923. DOI: 10.1155/2017/3960197. View

3.
Guan Z, Tan J, Gao W, Li X, Yang Y, Li X . Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway. J Cell Physiol. 2018; 234(1):500-508. DOI: 10.1002/jcp.26612. View

4.
Chen G, Shi Y, Liu M, Sun J . circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death Dis. 2018; 9(2):175. PMC: 5833724. DOI: 10.1038/s41419-017-0204-3. View

5.
Ji D, Chen G, Wang J, Ji S, Wu X, Lu X . Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3. Aging (Albany NY). 2020; 12(2):1643-1655. PMC: 7053641. DOI: 10.18632/aging.102705. View